Behcets Syndrome Market
According to Intent Market Research, the Behcet's Syndrome Market is expected to grow from USD 0.9 billion in 2023 at a CAGR of 10.4% to touch USD 1.8 billion by 2030. The Behcet's Syndrome Market is dominated by key players such as, Roche Holding AG, Novartis AG, Amgen Inc., Pfizer Inc., and Merck & Co.